The end of a dogma: the safety of doxycycline use in young children for malaria treatment

@inproceedings{Gaillard2017TheEO,
  title={The end of a dogma: the safety of doxycycline use in young children for malaria treatment},
  author={Tiphaine Gaillard and S{\'e}bastien Briolant and Marylin Madamet and Bruno Pradines},
  booktitle={Malaria Journal},
  year={2017}
}
Anti-malarial drug resistance to chloroquine and sulfadoxine–pyrimethamine has spread from Southeast Asia to Africa. Furthermore, the recent emergence of resistance to artemisinin-based combination therapy (ACT) in Southeast Asia highlights the need to identify new anti-malarial drugs. Doxycycline is recommended for malaria chemoprophylaxis for travel in endemic areas, or in combination with the use of quinine for malaria treatment when ACT is unavailable or when the treatment of severe malaria… CONTINUE READING
6
Twitter Mentions

References

Publications referenced by this paper.
SHOWING 1-10 OF 62 REFERENCES

for the treatment of malaria

WHO. Guideline
  • 3rd edition. Geneva: World Health Organization;
  • 2015
VIEW 3 EXCERPTS
HIGHLY INFLUENTIAL

Report 2016

WHO. World Malari
  • Geneva: World Health Organization;
  • 2016
VIEW 1 EXCERPT